The pharmacokinetics of ciprofloxacin excretion have been studied in 54 patients undergoing biliary and pancreatic operations with and without obstruction of the common bile duct. High concentrations were achieved in common duct bile within 20 minutes of intravenous injection and persisted for over 3 hours after 100 mg and for over 8 hours after 200 mg. The concentration of ciprofloxacin in the bile of functioning gall bladders was much greater than that in the common duct bile. Remarkably, it was identified in therapeutic concentrations in the bile of obstructed ducts. This and the rapid fall from initially high venous concentrations probably reflect diffusion from the circulation as a result of the exceptional tissue penetration. A unique feature of this study was the finding of clinically significant concentrations in the bile of obstructed ducts.
INTRODUCTION
Septic complications are common after biliary surgery performed without prophylactic antibiotics [1] [2] [3] but are uncommon when prophylactic antibiotics have been used2 '4. Ciprofloxacin is a quinolone related to nalidixic acid but having a broader spectrum of antimicrobial activity and fewer side effects5. Its spectrum of activity suggested to us that it might be useful as a prophylactic antibiotic in patients undergoing biliary surgery.
MATERIALS AND METHODS
Sixteen male and 38 female patients aged 22-86 years gave written informed consent for entry into the study. Seventeen showed some degree of obstruction to the drainage of bile due to stones (9) , pancreatic carcinoma (5) , carcinoma of the ampulla of Vater (1) , carcinoma of the common bile duct (1) and acute pancreatitis (1) .
Ciprofloxacin was injected intravenously as a single dose at varying times up to 8 hours before anaesthetic induction. Thirty-two patients were given 100 mg and 22 were given 200 mg. At operation samples were taken of common duct and gall Correspondence to: D.E.F. Tweedle, Department of Surgery, Withington Hospital, Manchester M20 8LR, UK bladder bile and venous blood. The time of infusion and sampling was recorded and samples were stored in oxalate at -20C until analysed by high performance liquid chromatography.
RESULTS
Two patients suffered wound infections and no adverse reactions to ciprofloxacin were observed. One patient developed an infection 9 days after cholecystectomy and Staphylococcus aureus of a phage type known to be prevalent in the hospital was isolated suggesting that this infection was exogenous. Another occurred 14 days after cholecystectomy, 1 week after discharge from hospital and swabs for culture were not obtained.
Patients with an obstructed common bile duct (CBD) were classed into partial or complete obstruction (Table 1) on the basis of the clinical picture, operative findings, radiological investigations and degree of disturbance of liver biochemistry. In 5 patients the common bile duct sample was insufficient for assay.
A series of mathematical models were examined to determine whether the time since infusion and/or degree of common bile duct obstruction could be used to predict ciprofloxacin concentrations in both venous blood and the common bile duct.
The models were developed using the method of maximum likelihood6; significance of the model parameters was set at the conventional 5% level. Optimum prediction was obtained when both the ciprofloxacin concentrations and times since infusion were converted to natural logarithms. The calculations were performed using the GLIM 3.77 computer package 7 at the University of Manchester Regional Computer
Centre.
Venous Blood
The prediction model for venous blood concentrations is detailed in Table 2 (i and ii).
The agreement between the model predictions and the observed assay values for the 100 mg dose are shown graphically in Figure 1 . A similar representation of the 200 mg dose data is shown in Figure 2 ; the numbers of patients with partial and total obstruction receiving 200 mg were too small for the derived prediction curves to be considered acceptable for clinical use, so these curves were not plotted.
Venous blood concentration was found to fall exponentially with time. Concentrations were consistently higher with the 200 mg dose than with the 100 mg dose. This difference was significantly more marked in the presence of partial obstruction (p 0.002). At toth the doses studied, ciprofloxacin appeared in high concentration in common duct bile within 20 minutes of its infusion. The early decay of the exponential curves probably reflects the rapid diffusion of the drug into the tissues. However, useful concentrations were maintained for up to 8 hours particularly after a 200 mg dose. It would appear that one hour before anaesthetic induction would be the ideal time to give this antibiotic as an intravenous infusion. In both groups common duct bile concentration decreased as the degree of obstruction increased. A remarkable feature of this study was the finding of clinically significant concentrations of the antibiotic in the bile from ducts that had been completely obstructed for up to two months. Perhaps the antibiotic diffuses directly into the common bile duct from the rich arterial plexuses of the common duct wall.
This study was designed to assess the pharmocokinetics of biliary extretion of this antibiotic and not prophylactic potential, but the results have relevance to prophylaxis. Escherichia The anique feature of this communication relates to a mathematical model which has been used to predict serum and bile duct concentrations depending on the time of administration, the dose of antimicrobial and the degree of obstruction. Unfortunately, this last variable is subjective using the analysis designed for these predictive parameters. More helpful would have been a model which had related serum and bile levels to serum bilirubin concentration. Nevertheless, the model seems to have been successful in non-obstructive patients. It is a pity that the numbers of patients with bile duct obstruction were too small to allow numerical analysis of their data. It is, of course, patients with bile duct obstruction that present the highest risk from infection in biliary surgery and it is precisely these patients in whom a mathematical model should be tested. 
